Page 2 - Solara Active Pharma Sciences News Today

Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 1249.61 Crore) operating in Pharmaceuticals sector.

​"The general level of awareness and compliance related to EHS (Environment Health & Safety) norms in case of manufacturing companies requires drastic improvement and urgent attention" said Nagaraj Krishnan, managing director, Aparajitha Corporate Services, a tech firm providing compliance solutions to over 2000 companies in India.

The increasing prevalence of chronic diseases could see the market for active pharmaceutical ingredients (APIs) growing by 7.5% per year, says a report by Prophecy Market Insights.

Spiracca Ventures was the buyer in the block deal, picking up the stake at a value of Rs 270.54 crore.

Smallcap World Fund offloaded shares in Dreamfolks Services, and Shriram Finance, but bought in Aavas Financiers via block deals.

Colestipol Market | Amneal Pharmaceuticals, Apothecon Pharmaceuticals, Cadila Healthcare

The pharma company also told exchanges that Aditya Puri has resigned as the chairman and non-executive director

US FDA inspected the the multi-product facility between and found it to be in an “acceptable state of compliance”, the company said

Solara Active Pharma Sciences Limited informed that following directors have resigned from the directorship of the company with effect from August 5, 2023, Mr. Aditya Puri has resigned from the...

Stocks to Watch on Thursday: JSW Steel will replace HDFC in the S&P BSE Sensex effective from July 13. Moreover, Zomato will replace the stock in S&P BSE 100 index